Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MLE4901 for Polycystic Ovary Syndrome (PCOS)
NCT02865915Phase 2Terminated
- Sponsor
- Millendo Therapeutics
- Start
- Jul 2016
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pavinetant in polycystic ovary syndrome (PCOS), sponsored by Millendo Therapeutics. Started Jul 2016; status: terminated.
02
Drugs
pavinetant
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT02865915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02865915.